Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis

18 Oct 2012

Abstract excerpt

Several molecular biomarkers have been suggested as predictors of outcome for pediatric ependymomas but deserve further validation in independent case series. We analyzed intracranial ependymomas belonging to a series of 60 patients prospectively treated according to the protocol sponsored by the Italian Association of Pediatric Hematology-Oncology. We used a tissue microarray to analyze nucleolin (NCL),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Glioma Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 23076205
DOI: 10.1093/neuonc/nos245

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 20 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysisPMID 23076205Read ↗

Multifactorial analysis of predictors of outcome in pediatric intracranial ependymomaSemantic proximity Read ↗

Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.Semantic proximity Read ↗

Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features – a retrospective analysis of the HIT ependymoma trial cohortSemantic proximity Read ↗

Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial EpendymomaSemantic proximity Read ↗

Pediatric Ependymoma: Biological PerspectivesSemantic proximity Read ↗

Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).Semantic proximity Read ↗

Molecular Staging of Intracranial Ependymoma in Children and AdultsSemantic proximity Read ↗

Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome.Semantic proximity Read ↗

Molecular subtyping of ependymoma and prognostic impact of Ki-67Semantic proximity Read ↗

Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.Semantic proximity Read ↗

Recent Advances in the Classification and Treatment of Ependymomas.Semantic proximity Read ↗

Put away your microscopes: the ependymoma molecular era has begunSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.